B+S Banksysteme (ETR:DTD2) Full Year 2024 Results
Key Financial Results
- Revenue: €13.0m (up 16% from FY 2023).
- Net income: €1.24m (up 180% from FY 2023).
- Profit margin: 9.5% (up from 3.9% in FY 2023). The increase in margin was driven by higher revenue.
- EPS: €0.20 (up from €0.071 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
B+S Banksysteme Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 67%.
Looking ahead, revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Software industry in Germany.
Performance of the German Software industry.
The company's shares are down 7.5% from a week ago.
Risk Analysis
Before you take the next step you should know about the 1 warning sign for B+S Banksysteme that we have uncovered.
Valuation is complex, but we're here to simplify it.
Discover if B+S Banksysteme might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About XTRA:DTD2
B+S Banksysteme
Provides software solutions for banks and financial service providers.
Undervalued with solid track record.